Biotech Archives - Page 115 of 795

2 minute read

Travere Therapeutics Announces Licensing Agreement With Renalys Pharma To Develop And Commercialize Sparsentan In Japan, South Korea, Taiwan, And Southeast Asian Nations

January 25, 5:40 PM

Travere Therapeutics, Inc., (NASDAQ:TVTX) announced that it has entered into an exclusive licensing agreement with Renalys Pharma, Inc., to bring sparsentan, a dual endothelin angiotensin receptor antagonist for the

TVTX

1 minute read

CHMP Issues Negative Opinion For Renewal Of Conditional Marketing Authorization For Translarna Following Re-Examination Procedure; Per European Regulations, The European Commission Has 67 Days To Adopt The Opinion

By Benzinga Newsdesk

January 25, 5:36 PM

PTC Therapeutics, Inc. (NASDAQ:PTCT) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a negative opinion following the re-examination

PTCT

2 minute read

Eli Lilly’s Famed Obesity And Diabetes Drug, Mounjaro, Comes To UK Patients, Wins Regulatory Clearance For Prefilled Injection Pen

By Vandana Singh

January 25, 5:11 PM

Eli Lilly's MHRA-approved Mounjaro KwikPen offers effective diabetes and weight management. Learn about the four-dose version's benefits for type 2 diabetes patients.

LLY

2 minute read

World’s Smallest Brain Stimulation Device For Movement Disorder: FDA Approved Abbott’s Liberta RC DBS system

By Vandana Singh

January 25, 4:19 PM

Abbott's Liberta RC DBS system, the world's smallest FDA-approved rechargeable deep brain stimulation device. With only 10 recharges a year, it's compatible with NeuroSphere Virtual Clinic, reducing the need for travel.

ABT

2 minute read

Axsome Depression Drug’s Commercial Success, Pipeline Potential Undervalued, Analyst Says

By Vandana Singh

January 25, 4:08 PM

Axsome Therapeutics' growth potential with RBC Capital's optimistic coverage. Auvelity's rapid Rx growth projects sales of $296M in 2024, outperforming estimates.

AXSM

2 minute read

Why Is Immunology Disease Focused Vera Therapeutics Stock Trading Higher Today?

By Vandana Singh

January 25, 3:07 PM

Vera Therapeutics' 72-week data from Phase 2b ORIGIN trial on atacicept for IgA nephropathy. Sustained reductions in Gd-IgA1, hematuria, and UPCR, with stable eGFR.

VERA

2 minute read

Vanda Pharmaceuticals Announces Publication Of An Article On “The Efficacy Of Tradipitant In Patients With Diabetic And Idiopathic Gastroparesis In Phase III Randomized Placebo-Controlled Clinical Trial” In The Clinical Gastroenterology And Hepatology

By Benzinga Newsdesk

January 25, 2:12 PM

Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ:VNDA) today announced the publication of an article titled "The Efficacy of Tradipitant in Patients with Diabetic and Idiopathic Gastroparesis in Phase III Randomized

VNDA

1 minute read

Why Is Cancer Focused LAVA Therapeutics Nano Cap Stock Trading Higher Today?

By Vandana Singh

January 25, 11:11 AM

LAVA Therapeutics collaborates with Merck on a clinical trial for anti-PD-1 therapy Keytruda in metastatic castration-resistant prostate cancer.

LVTX

4 minute read

ESSA Pharma Presents Updated Phase 1 Masofaniten Clinical Data At The 2024 ASCO Genitourinary Cancers Symposium

By Benzinga Newsdesk

January 25, 11:01 AM

Combination of masofaniten plus enzalutamide continues to be well tolerated with deep and durable reductions in PSA in patients with mCRPCPhase 2 dose expansion currently underway at the RP2CDs of masofaniten 600 mg BID

EPIX

3 minute read

QIAGEN Announces Partnership With Penn State University To Advance Microbiome Sciences

By Benzinga Newsdesk

January 25, 11:01 AM

QIAGEN (NYSE:QGEN, Frankfurt Prime Standard: QIA)))) today announced a first-in-kind collaboration with Penn State University in the United States to create a shared research and education facility for the

QGEN